| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/22/2006 | EP1636252A1 Statine derivatives for the treatment of alzheimer s disease |
| 03/22/2006 | EP1636242A1 Acylated imidazo (2,1-b) -1,3,4,-thiadia zole-2-sulfonamides, and uses thereof |
| 03/22/2006 | EP1636241A1 Imidazo (2,1-b) -1,3,4-thiadiazole sulfoxides and sulfones |
| 03/22/2006 | EP1636233A1 Cannabinoid receptor ligands and uses thereof |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636223A1 Benzothiazole derivatives as adenosine receptor ligands |
| 03/22/2006 | EP1636221A2 New azetidine compounds |
| 03/22/2006 | EP1636217A1 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/22/2006 | EP1636206A1 Imidazole derivatives as glutmate receptor antagonists |
| 03/22/2006 | EP1636196A1 Novel lactams and uses thereof |
| 03/22/2006 | EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 03/22/2006 | EP1636181A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1635851A2 Methods for treating cognitive impairment and improving cognition |
| 03/22/2006 | EP1635843A1 Therapy comprising dienogest for hormone replacement and depression |
| 03/22/2006 | EP1635833A1 Combinations for opioid-based treatment of pain comprising 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 03/22/2006 | EP1635828A1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/22/2006 | EP1635825A1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine |
| 03/22/2006 | EP1635823A1 Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
| 03/22/2006 | EP1635820A1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
| 03/22/2006 | EP1635811A2 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 03/22/2006 | EP1635807A1 Pharmaceutical combination comprising modafinil and another drug |
| 03/22/2006 | EP1635805A2 Sigma ligands for neuronal regeneration and functional recovery |
| 03/22/2006 | EP1635804A1 Use of iron for treating attention deficit hyperactivity disorder in children |
| 03/22/2006 | EP1635803A1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain |
| 03/22/2006 | EP1635799A2 Pharmaceutical formulations of amyloid inhibiting compounds |
| 03/22/2006 | EP1635783A2 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 03/22/2006 | EP1549650B1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/22/2006 | EP1538927A4 Fruit and/or vegetable derived composition |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1377586B1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 03/22/2006 | EP1377294B1 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 03/22/2006 | EP1337246B1 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 03/22/2006 | EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1244660B1 Methods and compositions for the treatment of pain |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1051161B1 Method for treating alzheimer's disease |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0871440B1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 03/22/2006 | CN1751042A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/22/2006 | CN1751040A Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs |
| 03/22/2006 | CN1751023A Piperidine-benzenesulfonamide derivatives |
| 03/22/2006 | CN1751021A Crystalline forms of optical enantiomers of modafinil and method for the production |
| 03/22/2006 | CN1751018A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750837A Superoxide anion decomposing agent |
| 03/22/2006 | CN1750826A Use of R-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain |
| 03/22/2006 | CN1750817A Use of the (1s, 2r) enantiomer of milnacipran for the preparation of a drug |
| 03/22/2006 | CN1748794A Use of aza decyl meta pentalkenylone compounds |
| 03/22/2006 | CN1748780A Niuhuang Qingxin dripping pill and its preparing method |
| 03/22/2006 | CN1748774A Brain tonifying preparation and new preparing method |
| 03/22/2006 | CN1748769A Method for preparing medicine for treating angioneurotic headache |
| 03/22/2006 | CN1748747A Chinese medicine compound medicinal preparation for pain killing of channels an dits preparing method |
| 03/22/2006 | CN1748739A Muscle relaxing waist strengthening preparation and new preparing method |
| 03/22/2006 | CN1748718A Fresh earthworm preparation with the functions of calming the liver and relieving convulsion, promoting blood circulation and removing obstruction in channels and its preparing method |
| 03/22/2006 | CN1748714A Method for preparing biological active substance of siphon-worm and its products |
| 03/22/2006 | CN1748701A New method for producing pyritinol hydrochloride for injection |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246319C Amino (thio) ether derivative |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246278C Hyperforin derivatives, the use thereof and formulations containing them |
| 03/22/2006 | CN1246011C Use of lotus root joint extract in preparing medicine for improving human insulin resistance and preventing obesity |
| 03/22/2006 | CN1245999C Use of seguinii in preparing medicine |
| 03/22/2006 | CN1245992C Medicine for treating diabetes nerve end inflammation |
| 03/22/2006 | CN1245983C Compound for prevention and treatment of neurodegenerative disease |
| 03/22/2006 | CN1245980C Oral slow-release and controlled-release preparation for curing depression |
| 03/22/2006 | CN1245958C Controlled release hydroxy-ketone |
| 03/21/2006 | USRE39030 Fluoxetine enteric pellets and methods for their preparation and use |
| 03/21/2006 | US7015333 Process for preparation of imidazolyl compounds |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015224 7-Tert-butyl-3-(2-fluorophenyl)-6-(2H-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3b) pyridazine for the treatment of anxiety and convulsions |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7014855 inducing an immune response against a peptide component of an amyloid deposit; active administration of an immunogen or passive administration of an antibody or an active fragment or derivative of the antibody; Alzheimer's disease |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2521933C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 03/21/2006 | CA2267251C Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |